This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Margaret H. Terhune, MD; Kevin D. Cooper, MD

Arch Dermatol. 1993;129(11):1484-1490.

Abstract
Background
Cutaneous T-cell lymphomas comprise a broad spectrum of neoplasia ranging from indolent to highly aggressive types. To determine subset lineage and malignant vs benign nature, morphologic analysis, immunophenotyping, and flow cytometry have been used. However, given the shortcomings of these methods, molecular genetic techniques, which take particular advantage of the clonal nature of malignancy, are now being applied to better characterize and diagnose these lymphomas.

Results
Each antigen-specific T cell and its clonal progeny has a unique rearrangement of its T-cell receptor gene such that it can recognize very specific antigenic epitopes. By visualizing these particular T-cell receptor gene rearrangements, Southern hybridization techniques and polymerase chain reaction amplification can detect clonal populations of T cells in the skin, blood, and lymph nodes of patients with T-cell leukemias and lymphomas. Clonal T-cell populations have also been found in cases of benign disorders such as lymphomatoid papulosis and pityriasis lichenoides et varioliformis acuta. Although these disorders usually have a benign outcome, they may represent dysplastic clonal lymphoid expansions with a high incidence of spontaneous regression.

Conclusions
Molecular genetic techniques have added to our ability to diagnose, characterize, and monitor the course of T-cell lymphomas and leukemias. In addition, they may provide insight into the pathogenesis of certain benign disorders.

(Arch Dermatol. 1993;129:1484-1490)

Author Affiliations
From the Department of Dermatology, University of Michigan School of Medicine (Drs Terhune and Cooper), and the Interdisciplinary Cutaneous Lymphoma Program, University of Michigan Cancer Center (Dr Cooper), Ann Arbor.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Molecular Diagnosis of Cutaneous Diseases
Sra et al.
Arch Dermatol 2005;141:225-241.
ABSTRACT | FULL TEXT  

Diagnostic role of tests for T cell receptor (TCR) genes
Hodges et al.
J. Clin. Pathol. 2003;56:1-11.
ABSTRACT | FULL TEXT  

The Clinical Use of Molecular Analysis of Clonality in Cutaneous Lymphocytic Infiltrates
Bachelez
Arch Dermatol 1999;135:200-202.
FULL TEXT